Alexandria Company for Pharmaceuticals and Chemical Industries (Alex Pharma) posted a 64.79% year-on-year (YoY) in net profit after tax in the first half (H1) of fiscal year (FY) 2024/2025.
Updated 1/19/2025 11:13:00 AM
Alexandria Company for Pharmaceuticals and Chemical Industries registered net profits valued at EGP 181.03 million in the first five months of fiscal year (FY) 2024/2025
Updated 12/22/2024 11:06:00 AMAlexandria Company for Pharmaceuticals and Chemical Industries posted a 66.45% year-on-year (YoY) increase in its net profit after tax in the first quarter (Q1) of fiscal year (FY) 2024/2025.
Updated 10/20/2024 9:58:00 AM
Alexandria Company for Pharmaceuticals and Chemical Industries posted a 71.4% year-on-year (YoY) increase in its net profit after tax in the fiscal year (FY) 2023/2024.
Updated 9/18/2024 10:14:00 AM
Alexandria Company for Pharmaceuticals and Chemical Industries posted a 74.19% year-on-year (YoY) increase in its net profit after tax in the fiscal year (FY) 2023/2024.
Updated 8/6/2024 9:40:00 AM
Alexandria Company for Pharmaceuticals and Chemical Industries’ board has approved the estimated budget for the fiscal year (FY) 2024/2025 with expected net profits after tax of EGP 377 million.
Updated 7/2/2024 11:51:00 AM
Alexandria Company for Pharmaceuticals and Chemical Industries reported a 77.3% year-on-year (YoY) increase in its net profit after tax in the first nine months of fiscal year (FY) 2023/2024.
Updated 5/7/2024 11:26:00 AM
Alexandria Company for Pharmaceuticals and Chemical Industries (Alex Pharma) (AXPH) posted an 88.91% year-on-year (YoY) in net profit after tax in the first half (H1) of fiscal year (FY) 2023/2024.
Updated 2/4/2024 9:42:00 AM
Alexandria Company for Pharmaceuticals and Chemical Industries posted a 19.6% year on year increase in its net profit after tax in the first 11 months of the fiscal year (FY) 2022/2023, from July 1st 2022 to May 31st 2023.
Updated 7/16/2023 12:14:00 PM